Lantern Pharma Ownership 2024 | Who Owns Lantern Pharma Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

9.95%

Insider Ownership

14.74%

Retail Ownership

75.30%

Institutional Holders

38.00

Lantern Pharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC3.39%-363,720--1,698,573Jun 30, 2024
NEWEDGE ADVISORS, LLC1.46%0.01%157,124-3,408-2.12%733,790Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.80%-86,347-1,027-1.18%403,336Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.76%0.00%81,80016,10024.51%382,006Jun 30, 2024
CM MANAGEMENT, LLC0.74%0.34%80,00015,00023.08%373,600Jun 30, 2024
DAVENPORT & CO LLC0.59%0.00%63,81463,814100.00%298,011Jun 30, 2024
BLACKROCK INC.0.37%-39,84120,182102.66%186,057Jun 30, 2024
REDMOND ASSET MANAGEMENT, LLC0.37%0.06%39,635-827-2.04%185,095Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.32%0.00%34,77934,779100.00%162,418Jun 30, 2024
HORIZON KINETICS ASSET MANAGEMENT LLC0.27%0.00%28,791--134,454Jun 30, 2024
SIGMA PLANNING CORP0.26%0.00%28,4001,5505.77%132,628Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.25%-26,482--123,670Jun 30, 2024
UBS GROUP AG0.24%-25,500--119,085Jun 30, 2024
STATE STREET CORP0.22%-23,652-1,400-5.59%110,455,000Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-18,4136,58555.67%85,989Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.0.16%0.00%17,000-2,000-10.53%79,390Jun 30, 2024
MERIDIAN WEALTH MANAGEMENT, LLC0.14%0.01%14,94514,945100.00%69,793Jun 30, 2024
JUMP FINANCIAL, LLC0.12%0.00%12,90012,900100.00%60,243Jun 30, 2024
NORTHERN TRUST CORP0.12%-12,813-10-0.08%59,837,000Jun 30, 2024
AVANTAX PLANNING PARTNERS, INC.0.11%0.00%11,640--54,359Jun 30, 2024

Lantern Pharma's largest institutional shareholder is VANGUARD GROUP INC, holding 3.39% of the company's total share outstanding, currently valued at $1.70M. The top 10 institutional shareholders own together 9.08% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CM MANAGEMENT, LLC0.74%0.34%80,00015,00023.08%373,600Jun 30, 2024
REDMOND ASSET MANAGEMENT, LLC0.37%0.06%39,635-827-2.04%185,095Jun 30, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.0.11%0.01%11,50011,500100.00%53,705Jun 30, 2024
MERIDIAN WEALTH MANAGEMENT, LLC0.14%0.01%14,94514,945100.00%69,793Jun 30, 2024
NEWEDGE ADVISORS, LLC1.46%0.01%157,124-3,408-2.12%733,790Jun 30, 2024
SIGMA PLANNING CORP0.26%0.00%28,4001,5505.77%132,628Jun 30, 2024
HORIZON KINETICS ASSET MANAGEMENT LLC0.27%0.00%28,791--134,454Jun 30, 2024
WOLFF WIESE MAGANA LLC0.01%0.00%600--2,802Jun 30, 2024
DAVENPORT & CO LLC0.59%0.00%63,81463,814100.00%298,011Jun 30, 2024
AVANTAX PLANNING PARTNERS, INC.0.11%0.00%11,640--54,359Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.0.16%0.00%17,000-2,000-10.53%79,390Jun 30, 2024
INDIANA TRUST & INVESTMENT MANAGEMENT CO0.01%0.00%750--3,503Jun 30, 2024
JUMP FINANCIAL, LLC0.12%0.00%12,90012,900100.00%60,243Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.76%0.00%81,80016,10024.51%382,006Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.32%0.00%34,77934,779100.00%162,418Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.01%0.00%1,339-2,017-60.10%6,253Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.10%0.00%10,896-1,108-9.23%50,884Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.80%-86,347-1,027-1.18%403,336Jun 30, 2024
VANGUARD GROUP INC3.39%-363,720--1,698,573Jun 30, 2024
UBS GROUP AG0.24%-25,500--119,085Jun 30, 2024

The largest Lantern Pharma shareholder by % of total assets is CM MANAGEMENT, LLC. The company owns 80.00K shares of Lantern Pharma (LTRN), representing 0.34% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DAVENPORT & CO LLC0.59%0.00%63,81463,814100.00%298,011Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.32%0.00%34,77934,779100.00%162,418Jun 30, 2024
BLACKROCK INC.0.37%-39,84120,182102.66%186,057Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.76%0.00%81,80016,10024.51%382,006Jun 30, 2024
CM MANAGEMENT, LLC0.74%0.34%80,00015,00023.08%373,600Jun 30, 2024
MERIDIAN WEALTH MANAGEMENT, LLC0.14%0.01%14,94514,945100.00%69,793Jun 30, 2024
JUMP FINANCIAL, LLC0.12%0.00%12,90012,900100.00%60,243Jun 30, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.0.11%0.01%11,50011,500100.00%53,705Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.09%-10,13510,135100.00%47,330Jun 30, 2024
FISHER ASSET MANAGEMENT, LLC0.09%-10,00010,000100.00%46,700Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.17%-18,4136,58555.67%85,989Jun 30, 2024
SIGMA PLANNING CORP0.26%0.00%28,4001,5505.77%132,628Jun 30, 2024
ROYAL BANK OF CANADA0.01%-1,4201,420100.00%7,000Jun 30, 2024
FMR LLC0.00%-530530100.00%2,474Jun 30, 2024
SIMPLEX TRADING, LLC0.03%-3,2002729.29%14,000Jun 30, 2024
FEDERATED HERMES, INC.0.00%-7474100.00%346,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-6969100.00%322Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-100--441Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.25%-26,482--123,670Jun 30, 2024
UBS GROUP AG0.24%-25,500--119,085Jun 30, 2024

As of Jun 30 2024, Lantern Pharma's largest institutional buyer is DAVENPORT & CO LLC. The company purchased 63.81K stocks of LTRN, valued at $298.01K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PATHWAY FINANCIAL ADVISORS LLC----25,001-100.00%-Jun 30, 2024
TUCKER ASSET MANAGEMENT LLC----11,500-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC1.46%0.01%157,124-3,408-2.12%733,790Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.01%0.00%1,339-2,017-60.10%6,253Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.0.16%0.00%17,000-2,000-10.53%79,390Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--2-1,700-99.88%10Jun 30, 2024
STATE STREET CORP0.22%-23,652-1,400-5.59%110,455,000Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.10%0.00%10,896-1,108-9.23%50,884Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.80%-86,347-1,027-1.18%403,336Jun 30, 2024
REDMOND ASSET MANAGEMENT, LLC0.37%0.06%39,635-827-2.04%185,095Jun 30, 2024
WELLS FARGO & COMPANY/MN0.07%-7,058-558-7.33%32,961Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----410-100.00%-Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----250-100.00%-Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC----200-100.00%-Jun 30, 2024
MORGAN STANLEY0.01%-600-115-16.08%2,802Jun 30, 2024
RHUMBLINE ADVISERS0.00%-208-20-8.77%971Jun 30, 2024
NORTHERN TRUST CORP0.12%-12,813-10-0.08%59,837,000Jun 30, 2024
HORIZON KINETICS ASSET MANAGEMENT LLC0.27%0.00%28,791--134,454Jun 30, 2024
WOLFF WIESE MAGANA LLC0.01%0.00%600--2,802Jun 30, 2024
AVANTAX PLANNING PARTNERS, INC.0.11%0.00%11,640--54,359Jun 30, 2024

As of Jun 30 2024, Lantern Pharma's biggest institutional seller is PATHWAY FINANCIAL ADVISORS LLC. The company sold -25.00K shares of LTRN, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DAVENPORT & CO LLC0.59%0.00%63,81463,814100.00%298,011Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.32%0.00%34,77934,779100.00%162,418Jun 30, 2024
JUMP FINANCIAL, LLC0.12%0.00%12,90012,900100.00%60,243Jun 30, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.0.11%0.01%11,50011,500100.00%53,705Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.09%-10,13510,135100.00%47,330Jun 30, 2024
FISHER ASSET MANAGEMENT, LLC0.09%-10,00010,000100.00%46,700Jun 30, 2024
ROYAL BANK OF CANADA0.01%-1,4201,420100.00%7,000Jun 30, 2024
FMR LLC0.00%-530530100.00%2,474Jun 30, 2024
FEDERATED HERMES, INC.0.00%-7474100.00%346,000Jun 30, 2024

Lantern Pharma's largest new institutional shareholder by number of shares is DAVENPORT & CO LLC, purchased 63.81K shares, valued at $298.01K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PATHWAY FINANCIAL ADVISORS LLC----25,001-100.00%-Jun 30, 2024
TUCKER ASSET MANAGEMENT LLC----11,500-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----410-100.00%-Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----250-100.00%-Jun 30, 2024
STONE HOUSE INVESTMENT MANAGEMENT, LLC----200-100.00%-Jun 30, 2024

Lantern Pharma's largest sold out institutional shareholder by shares sold is PATHWAY FINANCIAL ADVISORS LLC, sold -25.00K shares, valued at -, as of undefined.

Lantern Pharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.01%3,734--Mar 31, 2024
Listed Funds Trust0.01%28,791--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%355,378-99,265-21.83%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%90,4813400.38%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%5,987--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%657--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%8,807--Jan 31, 2024
Dimensional ETF Trust0.00%3,0213,01775425.00%Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%812--Jan 31, 2024
Blackstone Alternative Investment Funds0.00%200--Mar 31, 2024
iSHARES TRUST0.00%14,168-372-2.56%Mar 31, 2024
EQ ADVISORS TRUST0.00%976-334-25.50%Mar 31, 2024

Lantern Pharma's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 3.73K shares, compromising 0.01% of its total assets.

Lantern Pharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24382.70%
31 Mar, 243723.33%
31 Dec, 233011.11%
30 Sep, 23273.85%
30 Jun, 232618.18%
31 Mar, 2322-8.33%
31 Dec, 2224-11.11%
30 Sep, 22273.85%
30 Jun, 22264.00%
31 Mar, 2225-21.88%
31 Dec, 213233.33%
30 Sep, 212420.00%
30 Jun, 2120-16.67%
31 Mar, 2124140.00%
31 Dec, 2010-9.09%
30 Sep, 2011120.00%
30 Jun, 205-

As of 30 Jun 24, 38 institutions are holding Lantern Pharma's shares, representing an increase of 2.70% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,068,953-3.56%
31 Mar, 241,108,4291.09%
31 Dec, 231,096,470-3.68%
30 Sep, 231,138,3770.28%
30 Jun, 231,135,2236.74%
31 Mar, 231,063,492-0.28%
31 Dec, 221,066,432-25.80%
30 Sep, 221,437,2021.32%
30 Jun, 221,418,420-2.37%
31 Mar, 221,452,926-12.39%
31 Dec, 211,658,43918.40%
30 Sep, 211,400,6754.00%
30 Jun, 211,346,804-4.05%
31 Mar, 211,403,5961591.10%
31 Dec, 2082,999-48.17%
30 Sep, 20160,12731.09%
30 Jun, 20122,153-

Lantern Pharma (LTRN) has 1.07M shares outstanding as of 30 Jun 24, down -3.56% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 249.95%9.52%
31 Mar, 2410.22%10.02%
31 Dec, 2310.10%9.19%
30 Sep, 2310.49%9.59%
30 Jun, 2310.46%10.90%
31 Mar, 239.80%10.14%
31 Dec, 229.83%5.59%
30 Sep, 2213.26%7.73%
30 Jun, 2213.10%7.34%
31 Mar, 2213.36%5.78%
31 Dec, 2115.21%9.70%
30 Sep, 2112.52%8.63%
30 Jun, 2112.04%6.21%
31 Mar, 2113.93%781.83%
31 Dec, 201.33%20.13%
30 Sep, 202.58%66.73%
30 Jun, 201.96%-

As of 30 Jun 24, Lantern Pharma is held by 9.95% institutional shareholders, representing a 9.52% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2417-10.53%
31 Mar, 2419137.50%
31 Dec, 238-
30 Sep, 238-33.33%
30 Jun, 231250.00%
31 Mar, 238-27.27%
31 Dec, 221157.14%
30 Sep, 227-41.67%
30 Jun, 2212-7.69%
31 Mar, 2213-48.00%
31 Dec, 212566.67%
30 Sep, 2115-
30 Jun, 2115-31.82%
31 Mar, 2122266.67%
31 Dec, 206-25.00%
30 Sep, 20860.00%
30 Jun, 205-

17 institutional shareholders have increased their position in LTRN stock as of 30 Jun 24 compared to 19 in the previous quarter (a -10.53% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241220.00%
31 Mar, 2410-16.67%
31 Dec, 2312100.00%
30 Sep, 236-
30 Jun, 236-
31 Mar, 236-14.29%
31 Dec, 227-41.67%
30 Sep, 221220.00%
30 Jun, 221066.67%
31 Mar, 226500.00%
31 Dec, 211-80.00%
30 Sep, 215150.00%
30 Jun, 212100.00%
31 Mar, 211-66.67%
31 Dec, 20350.00%
30 Sep, 202-
30 Jun, 20--

12 institutional shareholders have reduced their position in LTRN stock as of 30 Jun 24 compared to 10 in the previous quarter (a 20.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24382.70%1,068,953-3.56%9.95%9.52%17-10.53%1220.00%
31 Mar, 243723.33%1,108,4291.09%10.22%10.02%19137.50%10-16.67%
31 Dec, 233011.11%1,096,470-3.68%10.10%9.19%8-12100.00%
30 Sep, 23273.85%1,138,3770.28%10.49%9.59%8-33.33%6-
30 Jun, 232618.18%1,135,2236.74%10.46%10.90%1250.00%6-
31 Mar, 2322-8.33%1,063,492-0.28%9.80%10.14%8-27.27%6-14.29%
31 Dec, 2224-11.11%1,066,432-25.80%9.83%5.59%1157.14%7-41.67%
30 Sep, 22273.85%1,437,2021.32%13.26%7.73%7-41.67%1220.00%
30 Jun, 22264.00%1,418,420-2.37%13.10%7.34%12-7.69%1066.67%
31 Mar, 2225-21.88%1,452,926-12.39%13.36%5.78%13-48.00%6500.00%
31 Dec, 213233.33%1,658,43918.40%15.21%9.70%2566.67%1-80.00%
30 Sep, 212420.00%1,400,6754.00%12.52%8.63%15-5150.00%
30 Jun, 2120-16.67%1,346,804-4.05%12.04%6.21%15-31.82%2100.00%
31 Mar, 2124140.00%1,403,5961591.10%13.93%781.83%22266.67%1-66.67%
31 Dec, 2010-9.09%82,999-48.17%1.33%20.13%6-25.00%350.00%
30 Sep, 2011120.00%160,12731.09%2.58%66.73%860.00%2-
30 Jun, 205-122,153-1.96%-5---

Lantern Pharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell930$6.25$5.81K59,326
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell1,859$6.33$11.77K57,467
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell930$6.25$5.81K59,326

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 26, 2024KEYSER D JEFFREYdirector-X-InTheMoneySell3,832$3.13$11.99K-
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell930$6.25$5.81K59,326
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell1,859$6.33$11.77K57,467
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell930$6.25$5.81K59,326

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 26, 2024KEYSER D JEFFREYdirector-X-InTheMoneyBuy3,832$3.13$11.99K-
Jul 26, 2024KEYSER D JEFFREYdirector-X-InTheMoneySell3,832$3.13$11.99K-
Jul 17, 2024SHARMA PANNAdirector, officer President and CEOA-AwardBuy70,000$4.35$304.50K70,000
Jul 17, 2024Maccecchini Maria-Luisadirector-A-AwardBuy5,000$4.35$21.75K5,000
Jul 17, 2024KEYSER D JEFFREYdirector-A-AwardBuy5,000$4.35$21.75K5,000
Jul 17, 2024Margrave David R.officer Chief Financial OfficerA-AwardBuy52,000$4.35$226.20K52,000
Jul 17, 2024Bhatia Kishor G.officer Chief Scientific OfficerA-AwardBuy35,000$4.35$152.25K35,000
Jul 17, 2024Chandru Vijaydirector-A-AwardBuy5,000$4.35$21.75K5,000
Jul 17, 2024Silberstein David S.director-A-AwardBuy5,000$4.35$21.75K5,000
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell930$6.25$5.81K59,326
May 28, 2024Kreis Leslie W.10 percent owner-S-SaleSell1,859$6.33$11.77K57,467
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell6,944$6.25$43.40K443,174
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell13,888$6.33$87.91K429,286
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell2,126$6.25$13.29K135,706
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell4,253$6.33$26.92K131,453
May 28, 2024Fletcher Aaron G.L.10 percent owner-S-SaleSell930$6.25$5.81K59,326

The last insider sell of Lantern Pharma's stock was made by KEYSER D JEFFREY on Jul 26 2024, selling 3,832 shares at $3.13 per share (valued at $11.99K).

Lantern Pharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202481800.00%
Q2 2024-12-
Q1 202462623.08%
Q4 2023-4-
Q4 202211010.00%
Q3 2022116183.33%
Q2 2022---
Q1 202222100.00%
Q4 20217--
Q1 2021---
Q2 20202411218.18%
Q2 2019-1-
Q1 2019---
Q4 2018---

8 total buy trades, and 1 total sell trades (buy/sell ratio of 8.00%) were made by Lantern Pharma's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024-12-
Q1 2024-24-
Q4 2023-4-
Q4 2022-10-
Q3 2022-6-
Q2 2022---
Q1 2022---
Q4 2021---
Q1 2021---
Q2 20201--
Q2 2019---
Q1 2019---
Q4 2018---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lantern Pharma's stocks.

Lantern Pharma Peer Ownership


TickerCompany
CUECue Biopharma, Inc.
GBIOGeneration Bio Co.
TFFPTFF Pharmaceuticals, Inc.
LYRALyra Therapeutics, Inc.
IMNMImmunome, Inc.

LTRN Ownership FAQ


Lantern Pharma is owned by institutional shareholders (9.95%), insiders (14.74%), and public (75.30%). The largest institutional shareholder of Lantern Pharma is VANGUARD GROUP INC (3.39% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).

Lantern Pharma's major institutional shareholders are VANGUARD GROUP INC, NEWEDGE ADVISORS, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and CM MANAGEMENT, LLC. The top five shareholders own together 7.16% of the company's share outstanding.

As of Jun 2024, there are 38 institutional shareholders of Lantern Pharma.

VANGUARD GROUP INC owns 363.72K shares of Lantern Pharma, representing 3.39% of the company's total shares outstanding, valued at $1.7M (as of Jun 2024).

As of Jun 2024, NEWEDGE ADVISORS, LLC holds 157.12K shares of Lantern Pharma (LTRN), compromising 1.46% of the company, valued at $733.79K.

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Lantern Pharma. The company owns 86.35K of the company's shares outstanding (worth $403.34K).